Final Agenda Is Now Available for 2nd Annual Stem Cell Congress

Production is now complete for the 2nd Annual Stem Cell Congress and co-located Cell & Gene Therapy Congress and 4th Annual Cell Culture & Bioprocessing Congress taking place on the 9th & 10th November 2015 in London. You can now download the final conference programme here to view who is speaking across the two days.  

The Stem Cell Congress will give attendees the opportunity to hear from those at the forefront of stem cell research share their knowledge on current challenges and exciting developments, as well as the insights into the future of the industry. Over two days, the congress will attract senior-level decision makers working at the cutting edge of the stem cell industry from the US and Europe. The programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, as well as ample networking opportunities, creating an ideal interactive platform for highlevel scientific and business discussion.  

Our Congress will cover 2 interactive streams:
 ●  Stem Cell & iPSC Bioprocessing and Manufacturing 
 ●  Stem Cell Therapy inc. Clinical & Commercialisation  

Oxford Global interviewed Francesco Saverio Tedesco, Senior Research Associate at UCL’s Department of Cell and Developmental Biology and a confirmed speaker of the Congress. 

You are speaking on the Developing A Human iPSC-Based Platform Of Muscle Differentiation at the Congress this year. What are you expecting to see from the stem cell industry over the next few years?  

“My gut feeling in terms of industry and commercial development is that there will be a lot going on in the upcoming years. I think that we’ll see more and more compounds and drugs going to the market thanks to drug screening platforms developed using induced pluripotent stem cells. This is not direct commercialisation of stem cells as a product, but stem cells are essential for the development of these compounds. It would probably be less straightforward to commercialise cell therapies, although there are models to do this, and I think industry/academia partnerships will become more and more common. Centres of excellence can, together with big pharma, develop joint products that can initially be tested in those centres and then, ideally, commercialised if possible […]”  

There will be over 40 speakers presenting across the two days including:
 ● John Harrington, Chief Scientific Officer, Athersys 
 ● Stewart Abbot, Vice President Translational Research, Fate Therapeutics 
 ● Jasmin Kee, Head of Engineering, ReNeuron 
 ● Roger Grau, Fellow, Cell Therapy, Novartis 
 ● Dusko Ilic, Reader in Stem Cell Science, King’s College London

Click here to review the full list of speakers: http://www.stemcells-congress.com/who-isspeaking/q-a/  
 
Attending this Congress will you:
 ● Full access to the 2 days of conference presentations 
 ● Free access to the Cell & Gene Therapy Congress and Cell Culture & Bioprocessing Congress 
 ● Lunch and Refreshments during the congress 
 ● Access to all networking activities  
 ● Access to exhibition area 
 ● Conference workbook and online access to conference materials, notes and presentations

Download the conference programme to find out more about this two day congress:  http://www.stemcells-congress.com/download-agenda-marketing/   

Reserve Your Place Today!
Registration continues and with only a limited number of places available, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk  or call on +44(0)1865 248 455 today. 

If you’re looking to present a poster, we have limited spaces available on a strictly first come first served basis. For further information regarding our poster presentations, or to find out more about this or any of our upcoming events in our Biologics series 2015 please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk  or call us on +44(0)1865 248455. 

You can also discover even more and discuss key the industry, from stem cell development and bioprocessing optimisation to commercial production and clinical trials: 

LinkedIn: Stem Cell Networking Group  

Twitter:  https://twitter.com/CellCultureConf